Latest Breaking News On - Ericl simpson - Page 1 : comparemela.com

Top Tools for Measuring AD in Clinical Practice Recommended

Consensus was reached during an in-person meeting attended by 34 individuals with diverse backgrounds.

United statesRobert sidburyEricl simpsonAmerican academy of dermatologyOregon health science universityEczema areaSeverity indexValidated investigator global assessmentGlobal assessmentHarmonizing outcome measuresEczema clinical practiceOregon healthScience universityOutcome setSeattle children

Ruxolitinib cream improves sleep disturbances, itch in children with atopic dermatitis

Ruxolitinib cream improves sleep disturbances, itch in children with atopic dermatitis
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesBygabriellem grassoEricl simpsonKristen dowdAmerican academy of dermatology annual meetingAmerican academyDermatology annualMedical dermatology professorOregon healthScience universityPatient oriented eczema measure

Ruxolitinib Cream Improves Itch, Sleep, Skin Pain in Children with Atopic Dermatitis

A secondary analysis from TRuE-AD3 shows ruxolitinib cream significantly benefits pediatric atopic dermatitis patient-reported outcomes.

United statesSan diegoEricl simpsonOregon health science universityAmerican academy of dermatologyAmerican academyOregon healthScience universityOriented eczema measureLife quality indexDermatology life quality indexPain numerical rating scaleRelated impairmentBody surface area

Dupilumab Improves AD Affecting the Hands, Feet

Dupilumab monotherapy was an effective and safe systemic treatment for patients with moderate to severe hand and foot atopic dermatitis.

United statesEricl simpsonOregon health science university in portlandJournal of the american academy dermatologyFoot investigatorGlobal assessmentPeak pruritus numeric rating scaleOregon healthScience universityAmerican academyAtopic dermatitisAtopic eczemaAdolescent medicineAdolescent healthQuality of lifeEalth related quality of life

Improvements in Atopic Dermatitis from Ruxolitinib Treatment Observed Past Vehicle-Controlled Period

This new post-hoc analysis of ruxolitinib cream for those with eczema indicates that continued treatment past 8 weeks may lead to further benefit for those with the skin disease.

United statesEricl simpsonEric simpsonOregon health science university in portlandGlobal assessmentOregon healthScience universityItch numerical rating scaleEczema areaSeverity indexDermatology life quality indexAtopic dermatitis